APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER AND DECEMBERApyxMedical2025-12-12T19:29:20-05:00November 10, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON NOVEMBER 11, 2021ApyxMedical2025-12-12T19:29:47-05:00October 4, 2021|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF WENDY LEVINE TO THE COMPANY’S BOARD OF DIRECTORSApyxMedical2025-12-12T19:30:11-05:00August 30, 2021|Read More
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOKApyxMedical2025-12-12T19:30:49-05:00August 12, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON AUGUST 12, 2021ApyxMedical2025-12-12T19:31:16-05:00July 12, 2021|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCEApyxMedical2025-12-12T19:31:44-05:00June 3, 2021|Read More
APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF RENUVION IN DERMAL RESURFACING PROCEDURESApyxMedical2025-12-12T19:32:06-05:00June 1, 2021|Read More
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOKApyxMedical2025-12-12T19:32:32-05:00May 12, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON MAY 12, 2021ApyxMedical2025-12-12T19:32:54-05:00April 12, 2021|Read More
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2021 FINANCIAL OUTLOOKApyxMedical2025-12-12T19:33:27-05:00March 31, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2020 FINANCIAL RESULTS ON MARCH 31, 2021ApyxMedical2025-12-12T19:33:50-05:00February 1, 2021|Read More
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2020 REVENUE RESULTSApyxMedical2025-12-12T19:34:13-05:00January 13, 2021|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE ICR CONFERENCE 2021ApyxMedical2025-12-12T19:34:37-05:00January 5, 2021|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDYApyxMedical2025-12-12T19:34:58-05:00November 23, 2020|Read More
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTSApyxMedical2025-12-12T19:35:21-05:00November 9, 2020|Read More
APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIESApyxMedical2025-12-12T19:35:52-05:00November 9, 2020|Read More
